209 related articles for article (PubMed ID: 26348911)
1. Non-β-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.
Zhang J; Zhou Q; Smith CD; Chen H; Tan Z; Chen B; Nani A; Wu G; Song LS; Fill M; Back TG; Chen SR
Biochem J; 2015 Sep; 470(2):233-42. PubMed ID: 26348911
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
Tan Z; Xiao Z; Wei J; Zhang J; Zhou Q; Smith CD; Nani A; Wu G; Song LS; Back TG; Fill M; Chen SR
Biochem J; 2016 Nov; 473(22):4159-4172. PubMed ID: 27623776
[TBL] [Abstract][Full Text] [Related]
3. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
Zhou Q; Xiao J; Jiang D; Wang R; Vembaiyan K; Wang A; Smith CD; Xie C; Chen W; Zhang J; Tian X; Jones PP; Zhong X; Guo A; Chen H; Zhang L; Zhu W; Yang D; Li X; Chen J; Gillis AM; Duff HJ; Cheng H; Feldman AM; Song LS; Fill M; Back TG; Chen SR
Nat Med; 2011 Jul; 17(8):1003-9. PubMed ID: 21743453
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.
Xiao Z; Guo W; Sun B; Hunt DJ; Wei J; Liu Y; Wang Y; Wang R; Jones PP; Back TG; Chen SRW
J Biol Chem; 2016 Nov; 291(47):24528-24537. PubMed ID: 27733687
[TBL] [Abstract][Full Text] [Related]
5. Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.
Zhong X; Sun B; Vallmitjana A; Mi T; Guo W; Ni M; Wang R; Guo A; Duff HJ; Gillis AM; Song LS; Hove-Madsen L; Benitez R; Chen SR
Biochem J; 2016 Nov; 473(21):3951-3964. PubMed ID: 27582498
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC
Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101
[TBL] [Abstract][Full Text] [Related]
7. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
Bai Y; Jones PP; Guo J; Zhong X; Clark RB; Zhou Q; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Semeniuk L; Guo A; Song LS; Duff HJ; Chen SR
Circ Res; 2013 Aug; 113(5):517-26. PubMed ID: 23856523
[TBL] [Abstract][Full Text] [Related]
8. Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-β-Blocking R-Enantiomer Carvedilol.
Seo K; Yamamoto Y; Kirillova A; Kawana M; Yadav S; Huang Y; Wang Q; Lane KV; Pruitt BL; Perez MV; Bernstein D; Wu JC; Wheeler MT; Parikh VN; Ashley EA
Circulation; 2023 Nov; 148(21):1691-1704. PubMed ID: 37850394
[TBL] [Abstract][Full Text] [Related]
9. Reduced threshold for store overload-induced Ca
Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
[TBL] [Abstract][Full Text] [Related]
10. Suppression of store overload-induced calcium release by hydroxylated metabolites of carvedilol.
Malig T; Xiao Z; Chen SR; Back TG
Bioorg Med Chem Lett; 2016 Jan; 26(1):149-53. PubMed ID: 26584883
[TBL] [Abstract][Full Text] [Related]
11. Novel carvedilol analogues that suppress store-overload-induced Ca2+ release.
Smith CD; Wang A; Vembaiyan K; Zhang J; Xie C; Zhou Q; Wu G; Chen SR; Back TG
J Med Chem; 2013 Nov; 56(21):8626-55. PubMed ID: 24124794
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of flecainide action in CPVT does not involve a direct effect on RyR2.
Bannister ML; Thomas NL; Sikkel MB; Mukherjee S; Maxwell C; MacLeod KT; George CH; Williams AJ
Circ Res; 2015 Apr; 116(8):1324-35. PubMed ID: 25648700
[TBL] [Abstract][Full Text] [Related]
13. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
Klipp RC; Li N; Wang Q; Word TA; Sibrian-Vazquez M; Strongin RM; Wehrens XHT; Abramson JJ
Heart Rhythm; 2018 Apr; 15(4):578-586. PubMed ID: 29248564
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation.
Danielsen TK; Manotheepan R; Sadredini M; Leren IS; Edwards AG; Vincent KP; Lehnart SE; Sejersted OM; Sjaastad I; Haugaa KH; Stokke MK
PLoS One; 2018; 13(11):e0207100. PubMed ID: 30399185
[TBL] [Abstract][Full Text] [Related]
15. Channel Activity of Cardiac Ryanodine Receptors (RyR2) Determines Potency and Efficacy of Flecainide and R-Propafenone against Arrhythmogenic Calcium Waves in Ventricular Cardiomyocytes.
Savio-Galimberti E; Knollmann BC
PLoS One; 2015; 10(6):e0131179. PubMed ID: 26121139
[TBL] [Abstract][Full Text] [Related]
16. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
Sung RJ; Lo CP; Hsiao PY; Tien HC
Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1625-38. PubMed ID: 21742998
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia.
Marks AR; Priori S; Memmi M; Kontula K; Laitinen PJ
J Cell Physiol; 2002 Jan; 190(1):1-6. PubMed ID: 11807805
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
Xiong J; Liu X; Gong Y; Zhang P; Qiang S; Zhao Q; Guo R; Qian Y; Wang L; Zhu L; Wang R; Hao Z; Wen H; Zhang J; Tang K; Zang WF; Yuchi Z; Chen H; Chen SRW; Zheng W; Wang SQ; Xu YW; Liu Z
J Mol Cell Cardiol; 2018 Apr; 117():26-35. PubMed ID: 29477366
[TBL] [Abstract][Full Text] [Related]
20. [Effect of carvedilol on ryanodine receptor in heart failure].
Li R; Yi QJ; Qian YR; Liu XY
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):603-7. PubMed ID: 16191273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
